| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-07 |
| mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-06 |
| mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
1e-06 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-06 |
| mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
3e-05 |